Wenxuan Bu
Overview
Explore the profile of Wenxuan Bu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Y, Huang K, Zhang M, Bu W, Yang X, Tian J, et al.
Plant Sci
. 2025 Feb;
355:112430.
PMID: 39978473
Distylium chinense has strong ecological adaptability and high ornamental value, which should have broad application prospects in urban landscaping. However, its low cutting rooting rate and slow rooting speed, as...
2.
Bu W, Huang Y, Chen L, Zhang M, Luo X, Zheng T, et al.
Plant Physiol Biochem
. 2024 Dec;
219:109405.
PMID: 39700913
Paeonia suffruticosa is a plant of Paeonia in Paeoniaceae. It is an important woody ornamental flower in the world. High temperature in summer hinders the growth of tree peony and...
3.
Yang X, Huang Y, Yao Y, Bu W, Zhang M, Zheng T, et al.
Genes (Basel)
. 2024 Mar;
15(3).
PMID: 38540443
The RNA-Seq and gene expression data of mature leaves under high temperature stress of 'Hu Hong' were used to explore the key genes of heat tolerance of peony. The weighted...
4.
Wang R, Bu W, Yang Y
J Healthc Eng
. 2021 Dec;
2021:6574491.
PMID: 34956573
Multiple myeloma (MM) is the second most commonly diagnosed hematological malignancy. Understanding the basic mechanisms of the metabolism in MM may lead to new therapies that benefit patients. We collected...
5.
Bu W, Li B, Feng L, Feng Q, Hu K, Xu Z, et al.
Am J Transl Res
. 2021 Nov;
13(10):11439-11449.
PMID: 34786070
Multiple myeloma (MM) is a malignant disease characterized by abnormal proliferation of clonal plasma cells. Based on the organic drug osalmid, the novel small molecule compound DCZ0858 was designed and...
6.
Hu L, Li B, Chen G, Song D, Xu Z, Gao L, et al.
J Exp Clin Cancer Res
. 2020 Jun;
39(1):105.
PMID: 32517809
Background: DCZ3301, a novel aryl-guanidino compound previously reported by our group, exerts cytotoxic effects against multiple myeloma (MM), diffused large B cell lymphoma (DLBCL), and T-cell leukemia/lymphoma. However, the underlying...
7.
Xi M, He W, Li B, Zhou J, Xu Z, Wu H, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2020 Apr;
52(4):401-410.
PMID: 32259210
Diffuse large B-cell lymphoma (DLBCL) is the most common category and disease entity of non-Hodgkin lymphoma. Osalmide and pterostilbene are natural products with anticancer activities via different mechanism. In this...
8.
Xiao W, Xu Z, Chang S, Li B, Yu D, Wu H, et al.
Cancer Lett
. 2018 Dec;
444:45-59.
PMID: 30583070
Rafoxanide is used in veterinary medicine for the treatment of fascioliasis. We previously repositioned the drug as the inhibitor of B-Raf V600E, but its anti-tumor effect in human cancer has...
9.
Yu D, Zhang Y, Chen G, Xie Y, Xu Z, Chang S, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2018 Jul;
50(8):782-792.
PMID: 29961897
Mantle cell lymphoma (MCL) is an aggressive and mostly incurable B-cell malignancy with frequent relapses after an initial response to standard chemotherapy. Therefore, novel therapies are urgently required to improve...
10.
Xie Y, Li B, Bu W, Gao L, Zhang Y, Lan X, et al.
Int J Oncol
. 2018 Jun;
53(2):823-834.
PMID: 29901111
Mantle cell lymphoma (MCL) is a distinct and highly aggressive subtype of B-cell non-Hodgkin lymphoma. Dihydrocelastrol (DHCE) is a dihydro-analog of celastrol, which is isolated from the traditional Chinese medicinal...